reference/21983589

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21983589

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Randomized Controlled Trial\|Research Support, U.S. Gov't, P.H.S.
endingPage	983
issn	0732-183X 1527-7755
issueIdentifier	6
pageRange	976-983
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	976
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a732008b6349fdb32a583d8e88260554
bibliographicCitation	Henderson IC, Berry DA, Demetri GD, Cirrincione CT, Goldstein LJ, Martino S, Ingle JN, Cooper MR, Hayes DF, Tkaczuk KH, Fleming G, Holland JF, Duggan DB, Carpenter JT, Frei E, Schilsky RL, Wood WC, Muss HB, Norton L. Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. J Clin Oncol. 2003 Mar 15;21(6):976–83. doi: 10.1200/jco.2003.02.063. PMID: 12637460.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e20d47453d41e758e26fd5852b402bcb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b20786bac79c17eab960357dbc3baae4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3701-9250 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_999d122e4347b9d6b1caa476adbc6d7d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a6c63d1a36d5629f35ff1fdf39240655 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9532c7f4d72e909404c933d725099eca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a8e9e9b8f87e99e40cdda745ae6b5391 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3ed6ca40ce8a4a926a5c1f6ae27ea683 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_134283d3f6632da66e67387cdd7d0e8a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_49e8bcef52fb29714defd4cf548b29f3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_92cb0a35454eac72ba5541b90c229500 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f202a88b295a9e778a5bc77269fd831c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b25fcbcadb9b36107fc8c1fbb3075ed1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_552e61e6d5b54ca7fd2c0655b98cc940 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_556dc8d58f8c3d412304e644b5f18ef1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4081b995fb7714cdf411822b0dcfb14e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_358ca230bafb28a7c1744b54437e4456 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c47556079cfb0b687e41b57982d22186 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_720a218380dd45af6dbf695cc29204e7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d223d7cee52b075bb96bb42d07c78b2
date	2003-03-15^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/12637460 https://doi.org/10.1200/jco.2003.02.063
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023 https://portal.issn.org/resource/ISSN/1527-7755 https://portal.issn.org/resource/ISSN/0732-183X
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer
discusses	http://id.nlm.nih.gov/mesh/M0001486 http://id.nlm.nih.gov/mesh/M0001348 http://id.nlm.nih.gov/mesh/M0006784 http://id.nlm.nih.gov/mesh/M0026156
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D000972Q000008 http://id.nlm.nih.gov/mesh/D017239Q000008 http://id.nlm.nih.gov/mesh/D001943Q000188 http://id.nlm.nih.gov/mesh/D001943Q000473
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D004317Q000008 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008207 http://id.nlm.nih.gov/mesh/D016016 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D000903Q000008 http://id.nlm.nih.gov/mesh/D005260
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128713593

Showing number of triples: 1 to 70 of 70.